DrugPatentWatch Database Preview
Drugs in Development Information for MGL-3196
» See Plans and Pricing
What is the drug development status for MGL-3196?
MGL-3196 is an investigational drug.
There have been 12 clinical trials for MGL-3196.
The most recent clinical trial was a Phase 1 trial, which was initiated on September 15th 2017.
The most common disease conditions in clinical trials are Non-alcoholic Fatty Liver Disease, Fatty Liver, and Liver Diseases. The leading clinical trial sponsors are Madrigal Pharmaceuticals, Inc., Celerion, and Worldwide Clinical Trials.
There are six US patents protecting this investigational drug and ninety-eight international patents.
Summary for MGL-3196
| US Patents | 6 |
| International Patents | 98 |
| US Patent Applications | 5 |
| WIPO Patent Applications | 14 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 1 (2017-09-15) |
| Vendors | 31 |
Recent Clinical Trials for MGL-3196
| Title | Sponsor | Phase |
|---|---|---|
| A Study to Evaluate the Safety and Biomarkers of Resmetirom (MGL-3196) in Non Alcoholic Fatty Liver Disease (NAFLD) Patients | Madrigal Pharmaceuticals, Inc. | Phase 3 |
| Drug Interaction Study of MGL-3196 With Clopidogrel | Madrigal Pharmaceuticals, Inc. | Phase 1 |
| A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis | Madrigal Pharmaceuticals, Inc. | Phase 3 |
Clinical Trial Summary for MGL-3196
Top disease conditions for MGL-3196
Top clinical trial sponsors for MGL-3196
US Patents for MGL-3196
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| MGL-3196 | Start Trial | Methods of synthesizing thyroid hormone analogs and polymorphs thereof | Madrigal Pharmaceuticals, Inc. (West Conshohocken, PA) Hoffmann-La Roche Inc. (Little Falls, NJ) | Start Trial |
| MGL-3196 | Start Trial | Thyroid hormone analogs | Hoffmann-La Roche Inc. (Nutley, NJ) | Start Trial |
| MGL-3196 | Start Trial | Thyroid hormone analogs | Hoffmann-La Roche Inc. (Nutley, NJ) | Start Trial |
| MGL-3196 | Start Trial | Prodrugs of thyroid hormone analogs | Hoffmann-La Roche Inc. (Nutley, NJ) | Start Trial |
| MGL-3196 | Start Trial | Method of synthesizing thyroid hormone analogs and polymorphs thereof | Madrigal Pharmaceuticals, Inc. (Fort Washington, PA) Hoffmann-La Roche Inc. (Nutley, NJ) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for MGL-3196
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| MGL-3196 | Argentina | AR092872 | 2032-09-17 | Start Trial |
| MGL-3196 | Australia | AU2013315017 | 2032-09-17 | Start Trial |
| MGL-3196 | Brazil | BR112015005891 | 2032-09-17 | Start Trial |
| MGL-3196 | Canada | CA2884481 | 2032-09-17 | Start Trial |
| MGL-3196 | Canada | CA3090070 | 2032-09-17 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
